Jingjing pharmaceutical co ltd (Manila)

Jingjing pharmaceutical co ltd

Jingjing Pharmaceutical Co., Ltd. was established in October 2007, covering an area of 310 mu, with a registered capital of 257.28 million yuan and more than 700 employees. It is a national high-tech enterprise and a national technological innovation demonstration enterprise specializing in the research, development, production and sales of sterile APIs, Amino acids and Vitamin nutrition fortifiers. In December 2015, it was successfully listed on the New Third Board securities market with the security code of 835033. Since its listing, it has received attention and recognition from all aspects in the capital market, introduced a number of market makers and strategic investment institutions, and entered the innovation layer in the first batch. After listing, the company has implemented three targeted additional offerings, with a total financing of 240 million yuan, mainly invested in core technology research and development, extension of the main product industry chain, project technology innovation, and replenishment of working capital, forming a number of core technical barriers, and gradually establishing the company s leading position in the subdivided industries. After years of tackling key problems, the company s technical team has obtained 67 patents, including 39 invention patents. It has successively passed a series of certifications such as high-tech enterprises, national and local joint engineering laboratories, provincial enterprise technology centers, and provincial engineering laboratories. It has set up academician workstations, and has been rated as Hebei Technological Innovation Demonstration Enterprise , Hebei Small and Medium sized Technological Enterprises , and the first batch of specialized, refined, and new demonstration enterprises in Hebei Province, It has successively won the honors of China s Top 100 Innovation Demonstration Enterprises , China s Reform and Innovation Demonstration Unit , and was included in the New Third Board Innovation Index and Third Board Medicine index model stocks.